Hemodynamic responses to In-Bed Cycle Exercise in the acute phase after moderate to severe stroke: A randomized controlled trial.
Klas SandbergMarie KleistPaul EnthovenMagnus Olof WijkmanPublished in: Journal of clinical hypertension (Greenwich, Conn.) (2021)
Hemodynamic responses to exercise in the acute phase after moderate to severe stroke have remained poorly investigated. The aim of this randomized controlled study, in which 52 (32 women) patients with moderate to severe stroke were randomized to three weeks of 20 minutes in-bed cycle exercise 5 days per week or to usual care, was to explore the systolic blood pressure (SBP) response to exercise and to evaluate the impact of the intervention on the resting and post-test systolic and diastolic blood pressures and heart rate, and on the systolic blood pressure response to exercise. We found that resting SBP decreased from baseline to post-intervention in both the intervention group (147.7 ± 18.1 mmHg to 125.3 ± 17.1 mmHg, P < .001) and in the control group (147.8 ± 23.7 mmHg to 131.4 ± 14.8 mmHg, P < .001) without a significant difference between the groups (interaction P = .308). However, there was a significant difference (interaction P = .010) regarding how Δ SBP (change in SBP from pre-test to post-test) changed from baseline to post-intervention. In the intervention group, Δ SBP increased from -1.0 ± 15.0 mmHg to 8.5 ± 9.4 mmHg, P = .009, whereas in the control group, Δ SBP decreased from 7.1 + 10.9 mmHg to 4.5 + 11.8 mmHg, P = .395. We conclude that patients randomized to in-bed cycle exercise seemed to normalize their blood pressure response to exercise to a larger extent than patients in the control group.
Keyphrases
- blood pressure
- heart rate
- high intensity
- randomized controlled trial
- physical activity
- heart rate variability
- end stage renal disease
- hypertensive patients
- resistance training
- ejection fraction
- double blind
- left ventricular
- open label
- heart failure
- chronic kidney disease
- newly diagnosed
- atrial fibrillation
- placebo controlled
- peritoneal dialysis
- prognostic factors
- healthcare
- pregnant women
- adipose tissue
- clinical trial
- palliative care
- phase ii
- patient reported outcomes
- blood glucose
- pain management
- high resolution
- polycystic ovary syndrome
- gestational age
- single molecule